Gene Mack

Mr. Gene C.
Mack is a President, CEO, CFO & Director at Gain Therapeutics, Inc. He is on the Board of Directors at Gain Therapeutics, Inc. Mr. Mack was previously employed as a Chief Financial Officer by ImCyse SA, a Chief Financial Officer & Treasurer by SELLAS Life Sciences Group, Inc., a Chief Financial Officer & Senior Vice President by Ascendia Pharmaceuticals, Inc., a Senior Director-Finance & Investor Relations by Edge Therapeutics, Inc., a Managing Director by Brean Capital LLC, an Executive Director by MIZUHO SECURITIES USA INC, a Research Analyst by Soleil Securities Corp., a Research Analyst by Lazard Capital Markets LLC, an Analyst by HSBC Securities (USA), Inc., an Analyst by Gruntal & Co. LLC, a Chief Financial Officer by OncoC4, Inc., and an Analyst by Ryan, Beck & Co., Inc. He received his undergraduate degree from Fordham University and an MBA from Fordham University.